As specified in the introduction, CHEK1 overexpression was frequently observed in solid tumors, indicating its role in the prognosis of melanoma, lung adenocarcinoma, hepatocellular carcinoma, bladder cancer, brain cancer, ovarian cancer, and BrC [17–21]. Here, CHEK1 is linked to melanoma.